Un tratamiento de la alergia al maní podría proteger a los pacientes de reacciones potencialmente mortales

A U.S. Food and Drug Administration panel is recommending approval of the first drug to treat life-threatening peanut allergies. It affects about 1.2 million children.

Fuente: Youtube